Live news related to DBV TECHNOLOGIES stock (FR0010417345): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
DBV Technologies stands out with notable gains this Tuesday morning, with shares reaching 3.73 euros in early trading. The food allergy-focused biotec…
DBV Technologies drops 2.23% this Monday afternoon, trading at 3.426 euros, amidst a generalized downturn on the Paris stock exchange. The biotech com…
DBV Technologies fell to 3.57 euros this Thursday amid a general pullback in European markets. However, the food allergy-focused biotech still shows a…
DBV Technologies rose 4.59% this Wednesday morning to €3.69, in a Parisian market buoyed by a CAC 40 that surged 3.97% during the session. The biotech…
On Tuesday, April 7, the stock of the biotech company specializing in food allergies saw a sharp decline in a generally downward Parisian market. With…
The stock of the French biotech company specializing in food allergies sharply declined this Thursday, April 2, bucking its remarkable yearly trend. D…
DBV Technologies saw a rise of 2.21% this Wednesday, reaching 3.705 euros, in a generally bullish Parisian market. The biotech company specializing in…
DBV Technologies has announced the filing of its Form 10-K with the U.S. Securities and Exchange Commission and its Universal Registration Document 20…
French biopharmaceutical company DBV Technologies closed the fiscal year 2025 with mixed signals: a financial stronghold with cash reserves multiplied…
DBV Technologies has announced its inclusion in the CAC Mid 60 and SBF 120 indexes following the annual review of the Euronext Paris indexes. This cha…
